Tasly Pharmaceutical Group Co., Ltd (SHA: 600535)

China flag China · Delayed Price · Currency is CNY
14.74
-0.02 (-0.14%)
Dec 30, 2024, 3:00 PM CST
-13.40%
Market Cap 20.93B
Revenue (ttm) 8.57B
Net Income (ttm) 881.05M
Shares Out 1.49B
EPS (ttm) 0.59
PE Ratio 23.85
Forward PE 15.23
Dividend 0.52 (3.60%)
Ex-Dividend Date Dec 6, 2024
Volume 6,454,761
Open 14.75
Previous Close 14.76
Day's Range 14.68 - 14.87
52-Week Range 12.24 - 17.77
Beta 0.41
Analysts n/a
Price Target n/a
Earnings Date Mar 4, 2025

About Tasly Pharmaceutical Group

Tasly Pharmaceutical Group Co., Ltd engages in the pharmaceutical business in China and internationally. It provides cardiovascular, anti-tumor, cold and fever, liver disease treatment, and other disease solutions. Tasly Pharmaceutical Group Co., Ltd was founded in 1994 and is based in Tianjin, China. [Read more]

Industry Pharmaceutical Preparations
Founded 1994
Employees 9,223
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600535
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.